Clinical Trial Update: Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating lansoprazole for gastroesophageal reflux in preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Premature Infants, Gastroesophageal Reflux | Phase 1, Phase 2 | Status: COMPLETED